Faculty & Staff Scholarship
2020

Localized cytokine responses to total knee arthroplasty and total
knee revision complications
Nicole Prince
West Virginia University

Julia A. Penatzer
West Virginia University

Matthew J. Dietz
West Virginia University

Jonathan W. Boyd
West Virginia University

Follow this and additional works at: https://researchrepository.wvu.edu/faculty_publications
Part of the Orthopedics Commons

Digital Commons Citation
Prince, Nicole; Penatzer, Julia A.; Dietz, Matthew J.; and Boyd, Jonathan W., "Localized cytokine responses
to total knee arthroplasty and total knee revision complications" (2020). Faculty & Staff Scholarship.
2935.
https://researchrepository.wvu.edu/faculty_publications/2935

This Article is brought to you for free and open access by The Research Repository @ WVU. It has been accepted
for inclusion in Faculty & Staff Scholarship by an authorized administrator of The Research Repository @ WVU. For
more information, please contact ian.harmon@mail.wvu.edu.

(2020) 18:330
Prince et al. J Transl Med
https://doi.org/10.1186/s12967-020-02510-w

Journal of
Translational Medicine
Open Access

RESEARCH

Localized cytokine responses to total
knee arthroplasty and total knee revision
complications
Nicole Prince1,2, Julia A. Penatzer1,2, Matthew J. Dietz2 and Jonathan W. Boyd2,3*

Abstract
Background: The study of localized immune-related factors has proven beneficial for a variety of conditions, and one
area of interest in the field of orthopaedics is the impact of implants and localized infections on immune response.
Several cytokines have shown increased systemic concentrations (in serum/plasma) in response to implants and
infection, but tissue-level cytokines have not been investigated as thoroughly.
Methods: This exploratory study investigated tissue-level cytokines in a cohort of patients (N = 17) in response to
total knee arthroplasty and total knee revision to better understand the immune response to implants and localized infection (e.g., prosthetic joint infection). The overall goal of this study was to provide insight into the localized
cytokine response of tissues and identify tissue-level markers specific to inflammation caused by implants vs. inflammation caused by infection. Tissues were collected across several anatomical locations and assayed with a panel of 20
human inflammatory cytokines to understand spatial differences in cytokine levels.
Results: In this study, six cytokines were elevated in implanted joints, as compared to native joints: IL-10, IL-12p70,
IL-13, IL-17A, IL-4, and TNF-α (p < 0.05). Seven cytokines showed infection-dependent increases in localized tissues:
IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, and MIP-1β (p < 0.05).
Conclusions: This study demonstrated that differences exist in tissue-level cytokines in response to presence of
implant, and some cytokines were specifically elevated for infection; these responses may be informative of overall tissue health. These results highlight the utility of investigating localized cytokine concentrations to offer novel
insights for total knee arthroplasty and total knee revision procedures, as well as their complications. Ultimately, this
information could provide additional, quantitative measurements of tissue to aid clinical decision making and patient
treatment options.
Keywords: Interleukin, Infection, Inflammation, Total knee arthroplasty, Total knee revision, Spatial distribution
Background
The inflammatory response of tissues involves a series of
biological events regulated by a number of immune factors, and the actions of these immune factors are partially reliant on the cytokines and chemokines produced
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in response to pathogens, foreign bodies, and other
stimuli [1–3]. These responses are of interest to the field
of orthopaedics, especially with regard to the immune
response to implants, infection, and chronic inflammation [4–6]. An elevated immune response has been
observed following total knee arthroplasty (TKA) procedures; increased levels of cytokines, particularly interleukin (IL)-1, IL-4, IL-6, IL-10, and tumor necrosis factor
alpha (TNF-α), have been shown both on a systemic level
(i.e., serum/plasma) as well as on a more localized level
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(i.e., synovial fluid) [7–9]. However, many aspects of this
response are not well understood. For example, a majority of TKA procedures are successful, but implant-related
and infection-related complications can negatively affect
a patient’s quality of life. Properly addressing these issues
is of high priority to the field of orthopaedics, especially
considering the increasing demand for joint replacement
[10]. Many studies have noted the pain, inflammation,
and dissatisfaction that can occur following these procedures, affecting approximately 20% of patients undergoing TKA [11, 12], but it is not entirely known what role
cytokines play in this chronic inflammatory response.
Infections, such as prosthetic joint infection (PJI), are
another serious complication and are a leading cause of
total joint failure [13]. PJI is a localized infection surrounding a prosthetic joint and can result following
implantation, often necessitating surgical intervention
[14]. PJI is a major concern following TKA/total knee
revision (TKR) procedures and can be difficult to treat.
The infections are often persistent and unable to be
resolved using conventional methods, presenting a challenge for clinicians [15]. The systemic immune response
to PJI has been studied extensively, but the localized tissue response is not as well understood. In order to better understand the immune response to implants and
localized infection, this study investigated levels of 20
inflammatory cytokines in localized tissue surrounding the joint. While defining the localized response to
implants and infection can be difficult [7–9], localized
cytokine responses have been investigated for other
pathological conditions. A few studies have characterized localized cytokine responses in trauma [16–18]
and respiratory infection [19], and these studies demonstrated that the local cytokine environment differs when
compared to systemically circulating levels. Currie et al.
[16] showed that differences in cytokine concentrations
exist in skeletal muscle samples in a spatially-dependent
manner using an animal model of traumatic injury. Similarly, Hauser et al. [18] observed differences in levels of
cytokines at the site of injury compared to systemic levels
in response to trauma in humans. Other research groups
have observed spatially-related differences of other
immune-related factors for stroke [20], and in response
to allergens [21] in animal models. These studies introduced the concept of using immune markers on a localized level to better understand these conditions.
TKA and TKR procedures trigger inflammatory cascades, initiating cytokine responses and elevating systemic cytokine concentrations; higher levels of cytokines
have been observed following these surgeries. The elevation in cytokine levels has been attributed to the trauma
of surgery as well as the introduction of implants into the
body [22, 23]. However, this inflammation is sometimes

Page 2 of 12

prolonged, which can cause major complications for
patients. The causes of chronic inflammation following
these procedures are still unknown, and resolution of the
inflammation is challenging [24]. Therefore, understanding the changes in inflammatory response specific to
implant-related inflammation is beneficial to improving
the outcome of these individuals.
Similarly, the localized response to PJI has not been
characterized to understand the local immune modulation in these cases. Many studies have investigated
systemically circulating levels of interleukins and
other cytokines for their roles in infection, and several
cytokines are used as diagnostics of PJI [25–27]. Several studies have specifically focused on the utility of
measuring IL-6 and IL-8 levels in serum for diagnosing and monitoring PJI, both of which have increased
specificity over conventional methods; this knowledge
has greatly benefitted the clinical treatment options for
PJI [28, 29]. However, PJI remains one of the most serious complications following revision knee arthroplasty.
In fact, infection is one of the most common causes for
revision, being implicated in 20.4% of all revision TKA
procedures between 2009 and 2013 [30]. While defining
the systemic response to sepsis and infection has paved
the way for improved diagnostics [31–33], less is known
about the environment of localized infections and what
role cytokines play in determining tissue health.
The present study focused on understanding differences in localized distributions of cytokines in TKA and
TKR procedures, with and without presence of infection,
using PJI as the model for localized infections. The ultimate goal of this study was to characterize the immune
modulation on a tissue level that occurs in response to
joint implantation and infection to better understand
localized tissue health. The information gained could aid
clinical management of these complications by narrowing down cytokines that are indicative of response to PJI.
It represents the first known investigation of tissue-level
cytokines in response to implant-related and infectionrelated complications, to our knowledge.

Patients, materials, and methods
Patients

Following Institutional Review Board (IRB) approval (IRB
Protocol #1709745853) and patient consent, six patients
undergoing primary total knee arthroplasty (TKA) and
11 patients undergoing total knee revision (TKR) procedures participated in the study (8 males, 9 females;
aged 45–82 years; body max index [BMI] 24.6–43.7).
Subjects were recruited over a 12-month period. All six
primary TKA patients were undergoing elective surgery
for total replacement of the knee joint with a diagnosis of
osteoarthritis. At the time of this study, this was the first
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arthroplasty procedure on either knee joint. In the TKR
group, patients were further characterized into aseptic
and septic revision procedures. Patients with aseptic revisions (N = 5) were undergoing revisions due to failures of
the prosthetic joint but did not show presence of infection. For ease of the reader, samples from these patients
will be referred to as aseptic TKR tissues. Patients with
septic revisions (N = 6) met clinical criteria for a PJI diagnosis as defined by the Musculoskeletal Infection Society
(MSIS) criteria [13]. Samples from these patients will be
referred to as septic TKR tissues. All six patients diagnosed with PJI were tissue culture positive: four tested
culture positive for Staphylococcus epidermidis, one for
Methicillin-sensitive Staphylococcus aureus (MSSA),
and one for Enterobacter cloacae. More patient information can be found in Table 1. Systemic C-reactive protein
(CRP) levels in serum are additionally listed as reference.
Collection of tissue samples

All TKA and TKR procedures were performed by a single surgeon with standard debridement and washing protocols. Tissues were collected at a total of four distinct
anatomical locations, broadly characterized into two tissue layers: four adjacent tissue layer (ATL) samples and
three radial tissue layer (RTL) samples. The ATL samples
came from the initial debridement. Tissues from the ATL
layer were closer to the knee joint (or prosthetic implant).
Conversely, RTL samples were taken from a tissue layer

further removed from the joint (or prosthetic implant)
after the surgeon completed debridement. The difference
in depth of the RTL tissues and ATL tissues was approximately 5–10 mm and was dependent on the individual
patient. Measurements were made from point of origin to
standardize tissue samples taken between patients. Tissues were taken at four anatomical locations illustrated in
Fig. 1. Briefly, the solid line circle represents location (1)
medial femoral condyle (F); the dashed line circle represents location (2) medial tibial plateau (T); the solid line
square represents location (3) lateral gutter (LG); and
the dashed line square represents location (4) posterior
capsule (PC). Anatomical locations 1–4 were collected
for the ATL layer, and locations 1–3 were collected for
the RTL layer. Location 4, PC, could not be taken in the
RTL layer due to proximity to neurovascular structures.
Therefore, a total of seven tissue samples were taken for
each patient.
Sample preparation

Tissues were collected during TKA and TKR procedures
in the operating room and immediately stored on dry
ice. Once all tissues had been collected for an individual
patient, they were washed with 1× cold phosphate-buffered saline (PBS) to remove blood and debris. Tissues
were grossly dissected using a scalpel to remove scar tissue or cement, then stored at − 80 ºC. When samples had
been collected for all patients, tissues were thawed on ice

Table 1 Patient information
ID

Sex

TKA/TKR

BMI (kg/m2)

Diabetic (Y/N)

CRP (mg/L)

Culture

P1

F

TKA

33.8

N

N/A

Negative

P2

F

TKA

39.8

N

N/A

Negative

P3

F

TKA

39.8

N

N/A

Negative

P4

M

TKA

29.7

Y

N/A

Negative

P5

M

TKA

24.6

N

N/A

Negative

P6

M

TKA

27.2

N

N/A

Negative

F1

F

TKR-aseptic

28.2

N

4.3

Negative

F2

F

TKR-aseptic

29.8

N

0.2

Negative

F3

F

TKR-aseptic

33.9

N

<1

Negative

F4

M

TKR-aseptic

40.4

Y

3.6

Negative

F5

M

TKR-aseptic

26.2

N

2.1

Negative

F6

F

TKR-septic

43.7

N

28.8

S. epidermidis

F7

F

TKR-septic

30.8

Y

161.4

S. epidermidis

F8

F

TKR-septic

41.9

N

21.7

E. cloacae

F9

M

TKR-septic

36.2

N

33.5

MSSA

F10

M

TKR-septic

33.8

Y

3.8

S. epidermidis

F11

M

TKR-septic

31.9

N

111.9

S. epidermidis

Six primary TKA and 11 revision TKR patients were enrolled in the study, creating a heterogenous cohort of males and females varying in age (45–82 years) and
comorbidities. Primary TKA patients have ID format P#; revision TKR patients have ID format F#. This table lists general patient information including the pathogen
for which each septic patient tested culture-positive following testing on the day of surgery. Serum CRP values were obtained pre-operatively in the revision setting.
Cultures were obtained from intraoperative tissue samples

Prince et al. J Transl Med

(2020) 18:330

Page 4 of 12

magnetic bead-based multiplex Inflammation Human
ProcartaPlex panel assay (Invitrogen, Carlsbad, CA) and
measured using a Bio-Plex 200 suspension array system
and Pro II Wash Station (Bio-Rad), according to the manufacturer’s instructions.
Statistical analysis

3

4

1

2

Fig. 1 Map of approximate tissue collection locations, shown with
prosthetic implant illustrated. Seven tissue samples were taken
for each patient; (1) the solid circle represents the medial femoral
condyle (denoted as F); (2) the dashed circle represents the medial
tibial plateau (denoted as T); (3) the solid square represents the lateral
gutter (denoted as LG); (4) the dashed square represents the posterior
capsule (denoted as PC). Locations 1–4 were taken for the ATL layer,
and locations 1–3 were taken for the RTL layer; separation between
ATL (closer to joint) and RTL (further from joint) was approximately
5–10 mm, depending on individual patient

and cut into sections approximately 30 mg in size; tissues
were homogenized by sonication in 500 µL cell lysis solution (Bio-Rad, Hercules, CA) containing 20 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich, St. Louis, MO).
Protein extraction was performed using methods adapted
from Hulse et al. [34]. Thawed samples were vortexed for
1–3 s and centrifuged at 5000×g for 5 min at 4 °C. The
supernatant was collected and tested for total protein
content using a Pierce BCA Protein Assay Kit (Thermo
Scientific, Waltham, MA), according to manufacturer’s
instructions. Absorbance values for total protein content
were determined on an Infinite M1000 multimode plate
reader (Tecan, Raleigh, NC).
Cytokine measurement

To standardize samples for total protein content, tissue
homogenates were individually diluted to a total protein
concentration of 900 µg/mL with cell lysis buffer (BioRad). Cytokine quantification was performed using a

Data were analyzed using Prism 5 (GraphPad, San Diego,
CA) and SAS JMP (Cary, NC). Standard curves were generated for each protein using either a four- (4PL) or fiveparameter logistic (5PL) regression model, depending
on the individual protein. Cytokine concentrations were
determined using standard curve interpolation, then corrected by dilution factor to compare tissue homogenates.
Cytokine concentrations are expressed as picograms of
cytokine per milliliter of tissue homogenate (pg/mL).
Samples with fluorescence intensity values below the
lower limit of quantitation (LLOQ) or above the upper
limit of quantitation (ULOQ) were omitted from statistical comparisons. Outliers were identified using the 1.5×
interquartile range (IQR) rule and omitted from analysis.
Two-way analysis of variance (ANOVA) with Bonferroni’s post-test was used to determine significant differences between primary TKA, aseptic TKR, and septic
TKR tissue samples at each tissue location. Each tissue
homogenate was tested in duplicate for cytokine concentration. Data are expressed as the mean ± standard error
of the mean (SEM).
Quadratic discriminant analysis was conducted to
evaluate the combined capacity of cytokine response to
predict the state of tissue. Using SAS JMP, all measured
responses were cast as covariates, and the “group” was
assigned as a classification category (primary TKA, aseptic TKR, septic TKR). The Shrink Covariances option was
applied to account for the different covariances within
the categories. Quadratic discriminant analysis is a predictive modeling tool, and when there are a large number
of variables compared to observations, as is the case in
this study, Shrink Covariances is frequently employed to
improve the stability and reduce prediction variance [35].
This analysis included 13 covariates; only those cytokines
that produced statistically significant two-way ANOVA
comparisons for either infection-specific or implantspecific comparisons were included: IL-1α, IL-1β, IL-6,
IL-8, monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1α, MIP-1β, IL-10,
IL-12p70, IL-13, IL-17A, and TNF-α. Biplot rays are plotted to indicate how each covariate influences the canonical space, with the direction and magnitude signifying
the degree of association with the respective group (primary TKA, aseptic TKR, septic TKR).
Due to the limited sample size, this study was not able
to control for age, sex, BMI, or other comorbidities.
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(See figure on next page.)
Fig. 2 Seven cytokines showed infection-dependent elevation in localized tissues. Individual tissue locations are shown for all groups. Two-way
ANOVAs with Bonferroni’s post-test were conducted to test for significant differences between groups at each individual location (p < 0.05).
Significant differences between groups at a particular location are marked as: * denotes significant difference from primary TKA (N = 6); # denotes
significant difference from aseptic TKR (N = 5); % denotes significant difference from septic TKR (N = 6); all symbols denote significance at the
p < 0.05 level

Pearson correlations were run between cytokine concentrations and age, sex, and BMI for each patient to analyze
the contribution of these variables. Bonferroni’s correction was applied to correct for multiple inferences, as
previously described by Bland et al. [36].

Results
Changes in cytokine concentrations were observed for
comparisons of primary TKA vs. aseptic TKR vs. septic
TKR tissues. Overall, cytokine concentrations were generally elevated in TKR (both septic and aseptic) compared to TKA, and septic TKR exhibited higher cytokine
levels than aseptic TKR for several cytokines. Seven
cytokines (IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α,
and MIP-1β) showed increased concentrations in septic
TKR tissues compared to both aseptic TKR tissues and
primary TKA tissues (p < 0.05). Six cytokines (IL-10,
IL-12p70, IL-13, IL-17A, IL-4, and TNF-α) showed differences in concentration between primary TKA and
TKR (both aseptic and septic) (p < 0.05), but these six
cytokines were not significantly different between aseptic
TKR and septic TKR. These comparisons are described
in detail over the following sections. Additional human
inflammatory cytokines were tested, but they did not
produce statistically significant comparisons in this
study: E-Selectin, granulocyte–macrophage colony-stimulating factor (GM-CSF), interferon-alpha (IFN-α), interferon-gamma (IFN-γ), and interferon gamma-induced
protein 10 (IP-10).
Seven cytokines exhibited infection‑specific elevation
in localized tissues

Seven cytokines showed an increase in concentration
that was dependent on the presence of localized infection: IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, and
MIP-1β (p < 0.05). For these cytokines, primary TKA
averages were lowest, with an increase in aseptic TKR
and further increase in septic TKR. For IL-1α, the average concentration of primary TKA tissues was 1.1 pg/mL,
and rose to 11.8 pg/mL in aseptic TKR; the concentration
was elevated to 30.3 pg/mL in septic TKR. Locationspecific differences are marked in Fig. 2, and it is clear
that most significant comparisons are present within
locations of the ATL layer. IL-1β showed a similar trend,
with a mean of 1.7 pg/mL in primary TKA tissues, which
rose to 5.4 pg/mL in aseptic TKR, and further elevated to

39.1 pg/mL in septic TKR. For IL-1β, the most marked
differences between groups came from comparisons of
locations ATL LG and ATL PC (Fig. 2). IL-6 followed,
with an average of 8.5 pg/mL in primary TKA, rising
to 24.2 pg/mL in aseptic TKR, and finally 610.7 pg/mL
in septic TKR. Location ATL PC showed the most dramatic increase in concentration in septic TKR compared
to other groups (Fig. 2). IL-8 levels were 7.6 pg/mL in
primary TKA, which increased to 91.1 pg/mL in aseptic
TKR, and rose to 553.9 pg/mL in septic TKR. Differences
in IL-8 were significant between at least two groups at all
locations besides ATL LG and ATL PC at p < 0.05 (note:
ATL PC for IL-8 not shown due to omission of outliers). For MCP-1, the average of primary TKA tissues was
113.0 pg/mL, which increased to 258.8 pg/mL for aseptic TKR, and further increased to 565.1 pg/mL for septic
TKR. RTL LG showed the most significant comparisons
between groups for MCP-1 (Fig. 2, p < 0.05). MIP-1α followed the same trend, with an average of 7.8 pg/mL for
primary TKA, which rose to 27.8 pg/mL in aseptic TKR,
and was elevated to 81.6 pg/mL in septic TKR. ATL locations showed the most significant increases in MIP-1α
between groups (Fig. 2, p < 0.05). For MIP-1β, primary
TKA tissues showed an average of 21.3 pg/mL and were
increased to 46.0 pg/mL for aseptic TKR and further
increased to 123.4 pg/mL in septic TKR. Locations ATL
T and ATL PC showed the most significant increases
between groups for MIP-1β (Fig. 2, p < 0.05). As shown in
Fig. 2, cytokine concentrations in the ATL layer locations
were generally higher than the RTL layer locations.
Six cytokines exhibited implant‑related elevation (primary
TKA vs. aseptic/septic TKR)

Six cytokines, IL-10, IL-12p70, IL-13, IL-17A, IL-4, and
TNF-α, exhibited higher levels in TKR tissues as compared to primary TKA tissues at a minimum of one
location (p < 0.05). In other words, there were significant differences (p < 0.05) between primary TKA and
aseptic/septic TKR, but there were no significant differences between aseptic TKR and septic TKR. For IL-10,
the average value in primary TKA was 0.9 pg/mL, 8.4 pg/
mL in aseptic TKR, and 6.6 pg/mL in septic TKR. All
locations showed significantly different comparisons to
aseptic TKR and septic TKR (Fig. 3, p < 0.05). With the
same general trend, IL-12p70 had an average of 5.7 pg/
mL in primary TKA, 30.7 pg/mL in aseptic TKR, and
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(See figure on next page.)
Fig. 3 Six cytokines showed implant-related elevation in localized tissues that was not infection-dependent. Individual tissue locations are shown
for all groups. Two-way ANOVAs with Bonferroni’s post-test were conducted to test for significant differences between groups at each individual
location (p < 0.05). Significant differences between groups at a particular location are marked as: * denotes significant difference from primary
TKA (N = 6); # denotes significant difference from aseptic TKR (N = 5); % denotes significant difference from septic TKR (N = 6); all symbols denote
significance at the p < 0.05 level

20.7 pg/mL in septic TKR. However, IL-12p70 only
showed one statistically significant comparison (p < 0.05)
at the ATL PC location between primary TKA and aseptic TKR (Fig. 3). For IL-13, the average in primary TKA
was 1.8 pg/mL, 9.6 pg/mL in aseptic TKR, and 9.9 pg/
mL in septic TKR. Locations ATL F, ATL T, and RTL F
exhibited significant comparisons between groups (Fig. 3,
p < 0.05). Following this trend, IL-17A average concentrations were 5.3 pg/mL in primary TKA, 16.3 pg/mL in
aseptic TKR, and 18.9 pg/mL in septic TKR. All locations
except RTL T showed significant comparisons (Fig. 3,
p < 0.05). For IL-4, average concentration in primary
TKA was 6.9 pg/mL, which rose to 19.6 pg/mL in aseptic
TKR, and further to 24.8 pg/mL in septic TKR. Again, all
locations except RTL T showed significant comparisons
(Fig. 3, p < 0.05). Finally, TNF-α followed the same trend,
with an average concentration of 16.9 pg/mL in primary
TKA, 71.1 pg/mL in aseptic TKR, and 86.8 pg/mL in septic TKR. All locations except RTL T showed significant
comparisons (Fig. 3, p < 0.05).

while they were actually septic. Further, there is overlap between the 95% confidence intervals for cytokine
profiles of aseptic TKR and septic TKR patients (Fig. 4),
which may be responsible for the misclassification.
Effects of age, sex, and BMI on cytokine concentrations

Quadratic discriminant analysis (QDA) revealed distinct
cytokine profiles for TKA vs. TKR

The research presented here did not control for age, sex,
or BMI due to the limited sample size of this exploratory
study. To better understand the connections between
cytokines of interest (IL-1α, IL-1β, IL-6, IL-8, MCP-1,
MIP-1α, MIP-1β, IFN-γ, IL-10, IL-13, IL-17A, IL-4, and
TNF-α) and these factors, Pearson correlations were run
and analyzed for statistical significance. When the Bonferroni’s correction was applied, as described in [36],
none of the correlations between cytokine levels and age,
sex, or BMI were significant (p > 0.05), but the correlations are displayed in Table 2 for transparency. Although
there is an established connection in the literature
between inflammatory cytokine levels and age, sex, and
BMI, the lack of significant Pearson correlation p-values
indicates these were not confounding variables for this
study [37–39].

The two-way ANOVA comparisons of cytokines between
different groups revealed seven cytokines that showed
infection-specific elevation (beyond inflammation caused
by implants), and six cytokines that showed increases due
to implants, but not infection (Figs. 2 and 3). To further
probe the structure of these cytokine profiles between
groups, quadratic discriminant analysis was conducted.
These 13 cytokines were included as covariates. The analysis classified the combined observed responses into predetermined groups of primary TKA, aseptic TKR, and
septic TKR. The group was predicted based on the covariate responses associated with each group, respectively.
For each group, all seven locations were included for all
individuals in that group, which means there were 42
counts for primary TKA (7 tissue locations, 6 patients),
35 values for aseptic TKR (7 tissue locations, 5 patients),
and 42 counts for septic TKR (7 tissue locations, 6
patients). In total, of 119 counts, only 8 were misclassified, indicating a good prediction ability of the model. All
8 misclassifications were errors of a prediction of aseptic TKR group, when the values were originally from the
septic TKR group. In other words, these individuals were
falsely classified as aseptic based on cytokine profiles

Discussion
Inflammation in response to implants and infection following TKA/TKR procedures remains a serious complication and is a high priority for clinicians. However,
not much is known about the local immune response
of the tissue surrounding the implant/infection. While
a variety of cytokines (and other biomarkers) have been
researched from a systemic view [40, 41], their clinical use is still debated [31–33, 42]. Further, the cytokine
responses have not been as well characterized on a localized tissue level. The tissue-level cytokine response may
add further understanding of the localized environment
and could give insight into tissue health that would aid
clinicians in the management of these post-surgical complications through surgical debridement. Tissue-level
cytokines have been measured with respect to spatial
gradients in traumatic injury [16–18], respiratory infection [19], stroke [20], and allergic response [21], and
these studies provided useful information regarding the
respective immune responses. These have established a
basis for this study to investigate the localized implantrelated and infection-specific tissue responses.
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Fig. 4 Quadratic discriminant analysis (QDA) revealed distinct groupings for primary TKA vs. TKR (aseptic or septic). Cytokines with significant
infection-dependent or implant-related elevations via two-way ANOVA were analyzed via quadratic discriminant analysis. Canonical scores for each
cytokine (covariate) were calculated, and the 95% confidence interval is shown for primary TKA (green), aseptic TKR (red), and septic TKR (blue). The
+ symbol represents the mean of each group. Biplot rays describe the degree of association of a certain cytokine with canonical variables

This study focused on defining the tissue-level cytokine
environment and modulation in response to implants
and infection across several anatomical locations. Many
human inflammatory cytokines have been implicated in
the systemic response to implants (i.e., in serum/plasma)
[43–45] and now aid in diagnosis of infection [46, 47].
However, this investigation is the first, to our knowledge, to assess multiple tissue locations surrounding the
joint to address implant-related vs. infection-specific
responses. Seven cytokines were identified as infectionspecific, showing elevated concentrations in the septic TKR cohort compared to both the aseptic TKR and
primary TKA cohorts: IL-1α, IL-1β, IL-6, IL-8, MCP-1,
MIP-1α, and MIP-1β (p < 0.05). Several of these cytokines
have illustrated their utility in the literature for diagnosis of PJI (i.e. IL-1α, IL-1β, IL-6, IL-8), but this is the first
instance of their investigation on a tissue level [30–33].
Generally, these seven cytokines were elevated in ATL

layer tissues compared to RTL layer tissues, which brings
to light the importance of proximity to joint in dictating cytokine response. Pro-inflammatory cytokines like
IL-1α, IL-1β, IL-6, and IL-8 have been noted for their
roles in early infection response, producing a warning signal of pathogen invasion, and this response
was present in septic TKR tissues [48, 49]. These early
cytokine indicators recruit factors like MCP-1, MIP-1α,
and MIP-1β that propagate the response to pathogens
through Th1 and Th2 immune signaling cascades [50,
51]. Six cytokines were identified as exhibiting a response
due to implantation, with elevations in aseptic and septic
TKR vs. primary TKA: IL-10, IL-12p70, IL-13, IL-17A,
IL-4, and TNF-α (p < 0.05). The elevated concentrations
of these cytokines in localized tissues highlighted the
degree of inflammation in implanted joints, without the
presence of infection, which is likely due to the presence of a foreign body. The implant-related inflammation
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Table 2 Pairwise pearson correlation values between cytokine concentrations and age, sex, and BMI
Cytokine

Primary TKA
Age

Aseptic TKR
Sex

BMI

Age

Septic TKR
Sex

BMI

Age

− 0.54

− 0.15

0.25

0.03

0.26

− 0.19

− 0.21

0.00

0.22

− 0.32

0.45

− 0.13

0.14

− 0.44

0.09

IL-1α

0.00

0.47

0.28

0.20

0.22

IL-1β

− 0.19

− 0.06

− 0.04

− 0.30

− 0.30

IL-8

0.03

0.59

0.25

0.06

MCP-1

0.04

0.13

0.14

− 0.07

MIP-1α

− 0.10

0.13

− 0.04

− 0.18

− 0.26

− 0.19

IL-6

MIP-1β
IL-10
IL-12p70
IL-13
IL-17A
IL-4
TNF-α

0.00

− 0.09

− 0.12

− 0.04

0.19
0.29

0.17

− 0.06

0.02

0.03

0.49

0.28

0.00

− 0.08

− 0.31

0.34

− 0.32

− 0.22

0.20

0.03

0.03

− 0.05

0.23

− 0.30

0.08

0.21

0.13

− 0.20

− 0.11

− 0.25

− 0.06

− 0.22

− 0.23

0.22

0.06

0.32

0.21

0.02

− 0.45

− 0.12

− 0.11

− 0.32

0.31

0.85

0.29

0.34

0.35

0.25

0.45

0.72

− 0.14

0.08

0.49
0.41

0.05

− 0.02

0.33

− 0.03

− 0.06

− 0.05

0.20

− 0.38

0.00

BMI

− 0.07

− 0.06

− 0.31

Sex

− 0.45

− 0.55

− 0.38

− 0.30

− 0.34

− 0.18

− 0.15

− 0.13

− 0.16

0.30
0.33

0.25

The pairwise correlation values are listed for each of the three groups: primary TKA, aseptic TKR, and septic TKR. Pearson correlation values are rounded to two decimal
places. No correlations were found to be significant at the p < 0.05 level after Bonferroni’s correction

reflected less of the macrophage activation present in
the septic TKR group, but exhibited elevation in antiinflammatory cytokines like IL-10, IL-4, and IL-13 frequently associated with bone healing [7]. IL-17A and
IL-12p70 have both pro- and anti-inflammatory roles,
but the specific contributions to foreign body response
are not well understood. Elevation of these cytokines,
as well as TNF-α, implies there may be dysregulation of
inflammatory response due to implant. These cytokines
were not significantly elevated in infection at the p < 0.05
level, so they may be considered as indicators of aseptic
or chronic inflammation that could be addressed with
future research associated with TKA. Further, QDA analysis illustrated that cytokine profiles are distinct between
all three cohorts, but there is significant overlap in the
95% confidence intervals of aseptic TKR and septic TKR.
While there are several cytokines that distinctly separate
these two cohorts, this analysis indicated that the degree
of inflammation experienced between these groups is
comparable. This finding agrees with the clinical decision
to address inflammation and perform revision surgery,
and these markers (IL-10, IL-12p70, IL-13, IL-17A, IL-4,
and TNF-α) may show promise as helpful diagnostic
monitoring markers for patients suffering from inflammatory complications in the absence of infection.
While this study had several limitations (i.e., single
operating surgeon, heterogeneous cohort of patients,
pathogen variability), it represents a novel characterization of tissue-level cytokines across different anatomical
locations in response to implants as well as infectionspecific inflammation. Further, these cytokines may give
insight into the health of localized tissue following these

procedures. Additionally, it highlights the utility of investigating a truly localized view of tissue health, by testing
tissues surrounding the joint following these procedures;
this approach could aid clinicians’ understanding of the
localized tissue to better support clinical decision making. At the time of publication, all patients had reached
at least the 1-year post-operative follow up without need
for revision, with no recurrent infections, and the predictive value of these cytokines for successful surgical outcomes is of interest in future studies. These cytokines
could potentially be incorporated to intra-operatively
assess the amount of inflammation during surgery, providing information in real time about the viability of tissues for debridement. A more focused investigation of
infection-specific markers IL-1α, IL-1β, IL-6, IL-8, MCP1, MIP-1α, and MIP-1β could provide insight into the
power of these cytokines to discriminate aseptic vs. septic tissues.

Conclusions
In conclusion, this exploratory pilot study identified
several cytokines that exhibited higher concentrations
in response to implant-related and infection-specific
post-operative inflammation. Some of these cytokines
have been previously implicated in chronic inflammation and infection following TKA/TKR on a systemic
level [11, 12, 30–33], and this study confirmed this
trend on a localized tissue level. Literature has already
illustrated that local inflammation is much more
important for early post-operative recovery for a few
markers [6], and this study expanded on that knowledge
to provide an extended view of inflammatory cytokines
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involved in tissue health. Future studies will build off
this localized tissue-level information to investigate
the mechanisms of dysregulation observed between the
groups.
Overall, investigating the localized tissue-level
cytokines to understand implant-related and infectionspecific inflammatory complications following knee
arthroplasty may offer insight into localized response
and provide new diagnostic and therapeutic options.
Although this study did not control for age, sex, or BMI,
these cytokines were not significantly correlated to these
variables, suggesting these were not confounding factors
(Table 2) in this study. Future work will focus on studies
to include a larger cohort of patients to control for a variety of factors, including age, sex, BMI, and comorbidities. Ultimately, this study provided a basis to study these
cytokines in surgical scenarios as a quantitative means
to verify clinical decisions. More research is needed to
confirm potential localized biomarkers that may be associated with chronic inflammation. In the future, larger
cohort studies could utilize the infection-specific biomarkers for retrospective review of patient outcomes
throughout the rehabilitation process.
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